Publications
2026
Gene therapy for Bietti crystalline corneoretinal dystrophy: a phase 1/2 clinical trial |
|
Mol Ther |
Details
Implantable ocular therapeutic systems: an insight into their clinical potential in the long-term treatment of ocular diseases |
|
Biofabrication |
Details
2025
Gestational hypertension increases risk of seizures in children and mice |
|
J Clin Invest |
Details
Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome |
|
Nat Commun |
Details
Near-Real Surgical Specimens (NRSS): A Novel Platform for Standardized Assessment of Suprachoroidal Drug Delivery |
|
Transl Vis Sci Technol |
Details
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial |
|
EClinicalMedicine |
Details
Elevated PRDM13 Disrupts Photoreceptor Function and Survival in the Mammalian Retina |
|
Invest Ophthalmol Vis Sci |
Details
3D Bioprinting of Cellular Therapeutic Systems in Ophthalmology: from Bioengineered Tissue to Personalized Drug Delivery |
|
Curr Ophthalmol Rep |
Details
Ophthalmic drug discovery and development using artificial intelligence and digital health technologies |
|
NPJ Digit Med |
Details
Automated animal gimbal steering for retinal imaging and stimulation |
|
Biomed Opt Express |
Details
Automated animal gimbal steering for retinal imaging and stimulation |
|
Biomed Opt Express |
Details
A synthetic opsin restores vision in patients with severe retinal degeneration |
|
Mol Ther . |
Details
Enhanced genotype-phenotype analysis using multimodal adaptive optics and 3D protein structure in Bietti Crystalline Dystrophy |
|
Am J Ophthalmol Case Rep. |
Details
Artificial intelligence's contribution to biomedical literature search: revolutionizing or complicating? |
|
PLOS Digit Health |
Details
Response: Promise and open questions of optogenetic vision restoration by MCO |
|
Molecular Therapy |
Details